FREE ON-DEMAND WEBINAR

How to make the right clinical trade-offs between FDA and EU MDR

For many MedTech companies across the UK and Europe, managing clinical trials that meet both FDA and EU MDR requirements has become increasingly complex. It’s not just about ticking regulatory boxes, it’s about making smart decisions that keep trials on track, budgets under control, and timelines realistic.

Join Carl Taylor, Business Development Director at Greenlight Guru, and John Thomas, Director of Strategic Delivery at 1Med, for a practical conversation on what it really takes to run clinical trials successfully in 2025. This session will highlight the trade-offs companies are making and how to design clinical trials that are both compliant and operationally sustainable.

We'll cover:

• FDA vs EU: The current clinical landscape and operational realities for MedTech manufacturers
• Strategic considerations and when might a regional shift make sense, and what does a hybrid approach actually look like?
• How streamlining clinical data collection can help accelerate trial execution and support submissions
• Where MedTech-specific tools can reduce trial cost, improve data quality, and support PMCF integration